Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Regenxbio (RGNX) Receivables - Net (2016 - 2025)

Regenxbio has reported Receivables - Net over the past 12 years, most recently at $28.7 million for Q4 2025.

  • Quarterly results put Receivables - Net at $28.7 million for Q4 2025, up 36.97% from a year ago — trailing twelve months through Dec 2025 was $28.7 million (up 36.97% YoY), and the annual figure for FY2025 was $28.7 million, up 36.97%.
  • Receivables - Net for Q4 2025 was $28.7 million at Regenxbio, up from $28.1 million in the prior quarter.
  • Over the last five years, Receivables - Net for RGNX hit a ceiling of $48.7 million in Q3 2021 and a floor of $16.4 million in Q1 2024.
  • Median Receivables - Net over the past 5 years was $28.4 million (2025), compared with a mean of $29.3 million.
  • Biggest five-year swings in Receivables - Net: plummeted 61.21% in 2021 and later skyrocketed 36.97% in 2025.
  • Regenxbio's Receivables - Net stood at $34.7 million in 2021, then fell by 14.74% to $29.6 million in 2022, then fell by 13.84% to $25.5 million in 2023, then dropped by 17.83% to $20.9 million in 2024, then skyrocketed by 36.97% to $28.7 million in 2025.
  • The last three reported values for Receivables - Net were $28.7 million (Q4 2025), $28.1 million (Q3 2025), and $21.8 million (Q2 2025) per Business Quant data.